Inhibition of C1q, initiator of the classical complement cascade, by ANX005 for the treatment of Guillain-Barré Syndrome: Results from a Phase 1b study (.pdf download for full audio )

Inhibition of C1q, initiator of the classical complement cascade, by ANX005 for the treatment of Guillain-Barré Syndrome: Results from a Phase 1b study (.pdf download for full audio ) - Annexon Biosciences